Literature DB >> 2680183

Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture.

D Kwiatkowski1, J G Cannon, K R Manogue, A Cerami, C A Dinarello, B M Greenwood.   

Abstract

To investigate the involvement of tumour necrosis factor (TNF) in human malaria, we studied TNF production in patients infected with Plasmodium falciparum, and in co-cultures of human mononuclear cells and malaria parasites in vitro. In the examined sample, plasma TNF levels of over 39 pg/ml were detected in the plasma of 59% of Gambian children with acute malaria, 17% of convalescents, 9% of children with mild infections other than malaria, and 7% of healthy Gambian adults. Mononuclear cells of acute malaria patients, when stimulated with endotoxin in vitro, secreted twice as much TNF as did those of convalescent individuals, and three times that of healthy adult controls. Erythrocytic cultures of P. falciparum stimulated increased TNF secretion by mononuclear cells from uninfected individuals, and a sharp rise in the rate of secretion occurred shortly after schizont rupture. We suggest that malaria fever is mediated, at least in part, through paroxysmal TNF release associated with schizont rupture.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680183      PMCID: PMC1542045     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

2.  Immunological reactivity and bioactivity of tumour necrosis factor.

Authors:  C M Petersen; B K Møller
Journal:  Lancet       Date:  1988-04-23       Impact factor: 79.321

3.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

5.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

6.  Cell-mediated immunity in protection and pathology of malaria.

Authors:  I A Clark
Journal:  Parasitol Today       Date:  1987-10

7.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

8.  Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis?

Authors:  I A Clark
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

9.  Raised serum levels of tumour necrosis factor in parasitic infections.

Authors:  P Scuderi; K E Sterling; K S Lam; P R Finley; K J Ryan; C G Ray; E Petersen; D J Slymen; S E Salmon
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

10.  Cytokine appearance in human endotoxemia and primate bacteremia.

Authors:  D G Hesse; K J Tracey; Y Fong; K R Manogue; M A Palladino; A Cerami; G T Shires; S F Lowry
Journal:  Surg Gynecol Obstet       Date:  1988-02
View more
  51 in total

1.  Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria.

Authors:  K Kemp; B D Akanmori; V Adabayeri; B Q Goka; J A L Kurtzhals; C Behr; L Hviid
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Link between immune response and parasite synchronization in malaria.

Authors:  Igor M Rouzine; F Ellis McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-05       Impact factor: 11.205

3.  MRP 8/14 as marker for Plasmodium falciparum-induced malaria episodes in individuals in a holoendemic area.

Authors:  G Bordmann; G Burmeister; S Saladin; H Urassa; S Mwankyusye; N Weiss; M Tanner
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

Authors:  R Harpaz; R Edelman; S S Wasserman; M M Levine; J R Davis; M B Sztein
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model.

Authors:  Gordon A Awandare; Prakasha Kempaiah; Daniel O Ochiel; Paolo Piazza; Christopher C Keller; Douglas J Perkins
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

6.  Association of high plasma TNF-alpha levels and TNF-alpha/IL-10 ratios with TNF2 allele in severe P. falciparum malaria patients in Sri Lanka.

Authors:  M K Perera; N P Herath; S L Pathirana; M Phone-Kyaw; H K Alles; K N Mendis; S Premawansa; S M Handunnetti
Journal:  Pathog Glob Health       Date:  2013-01       Impact factor: 2.894

7.  Ring-infected erythrocyte surface antigen (Pf/155RESA) induces tumour necrosis factor-alpha production.

Authors:  S Picot; F Peyron; P Deloron; C Boudin; B Chumpitazi; G Barbe; J P Vuillez; A Donadille; P Ambroise-Thomas
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

8.  Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax.

Authors:  C A Bate; J Taverne; N D Karunaweera; K N Mendis; D Kwiatkowski; J H Playfair
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Plasmodium falciparum varies in its ability to induce tumor necrosis factor.

Authors:  R J Allan; A Rowe; D Kwiatkowski
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.